ELEPHAS BIOSCIENCES AND TES PHARMA COLLABORATE TO ADVANCE TRANSLATIONAL RESEARCH FOR LUNG CANCER THERAPY
Why now
Thesis: Lung cancer research deal, no ticker
Catalyst to watch: Clinical data readouts
Main risk: Private parties; early-stage research
Why it matters
A translational lung cancer research collaboration involves private biotechs only.
Details
Tes Pharma Will Use the elive™ Platform to Functionally Evaluate Response to TES-4207 in Live Tumor Fragments as a Monotherapy and in Combination With Immune Checkpoint Inhibitors MADISON, Wis., Sept. 24, 2026 /PRNewswire/ -- Elephas Biosciences Corporation, developer of a functional...
Related assets & topics
HealthcareSources
- prnewswire · 2026-09-24 14:00 UTC